The World Bank lowered its China growth forecast for the year from 4.3 percent predicted in June to 2.7 percent due to the impact of the pandemic and property sector weaknesses on its economy.
The institution also slashed its forecast for next year from 8.1 percent down to 4.3 percent.
Many analysts believe that China's GDP growth target of around 5.5 percent for the year is now unattainable.
According to the World Bank, outbreaks and growth slowdowns in China have been followed by uneven recoveries.
Disruption to businesses has continued in China as cases surge and some restrictions remain in place.
Health officials have acknowledged that since bulk testing criteria were removed, official data no longer accurately reflect domestic infections.
The IMF forewarned last week that it will likely also reduce its predictions for China, blaming a sustained rise in cases.
The fund revised its growth forecast for China in October, lowering it to 3.2 percent this year, the lowest level in decades from the 4.4 percent it expected the previous year.
According to IMF chief Kristalina Georgieva, they are very likely to downgrade the growth projections for China, both for 2022 and 2023,
As China moves forward with the reopening, experts worry that it is ill-prepared to handle the next wave of diseases since millions of susceptible elderly people have not yet had all of the recommended vaccinations.


Thailand Plans Dual-Class Shares to Revive IPO Market
Europol Warns Bitcoin Wallets Face Quantum Computing Risk
Asian Currencies Mixed as Yen Weakens, Dollar Holds Firm
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
China Shuts 670 Banks as Bitcoin Eyes Financial Risks
US Stock Futures Flat as Fed Minutes, Earnings Loom
JPMorgan CEO Jamie Dimon Warns Mythos AI Raises Cyber Risk Tenfold
Crypto Market Selloff Wipes Out $100B as Bitcoin Falls Below $83K
Zcash Privacy Demand Rises as AI Exposes Bitcoin Transactions
3 clinical-grade skincare creams you really shouldn’t buy online
European Stocks Fall as Oil Rises Ahead of Fed Minutes
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
U.S. Issues Cuba Health Alert as Illnesses Rise
Nasdaq Hits Record High as Tech Stocks Lift Wall Street
OKX Raises Fresh Funding at $25 Billion Valuation
Zcash Prepares for NU7 Upgrade as Zebra Gets Key Security Fixes 



